Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.

Although cell therapy of the failing heart by intramyocardial injections of myoblasts to results in regenerative benefit, it has also been associated with undesired and prospectively fatal arrhythmias. We hypothesized that intramyocardial injections of myoblasts could enhance inflammatory reactivity...

Full description

Bibliographic Details
Main Authors: Tommi Pätilä, Shigeru Miyagawa, Yukiko Imanishi, Satsuki Fukushima, Antti Siltanen, Eero Mervaala, Esko Kankuri, Ari Harjula, Yoshiki Sawa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4393220?pdf=render
_version_ 1828529109182971904
author Tommi Pätilä
Shigeru Miyagawa
Yukiko Imanishi
Satsuki Fukushima
Antti Siltanen
Eero Mervaala
Esko Kankuri
Ari Harjula
Yoshiki Sawa
author_facet Tommi Pätilä
Shigeru Miyagawa
Yukiko Imanishi
Satsuki Fukushima
Antti Siltanen
Eero Mervaala
Esko Kankuri
Ari Harjula
Yoshiki Sawa
author_sort Tommi Pätilä
collection DOAJ
description Although cell therapy of the failing heart by intramyocardial injections of myoblasts to results in regenerative benefit, it has also been associated with undesired and prospectively fatal arrhythmias. We hypothesized that intramyocardial injections of myoblasts could enhance inflammatory reactivity and facilitate electrical cardiac abnormalities that can be reduced by epicardial myoblast sheet delivery. In a rat model of ischemic heart failure, myoblast therapy either by intramyocardial injections or epicardial cell sheets was given 2 weeks after occlusion of the coronary artery. Ventricular premature contractions (VPCs) were assessed, using an implanted three-lead electrocardiograph at 1, 7, and 14 days after therapy, and 16-point epicardial electropotential mapping (EEPM) was used to evaluate ventricular arrhythmogenicity under isoproterenol stress. Cardiac functioning was assessed by echocardiography. Both transplantation groups showed therapeutic benefit over sham therapy. However, VPCs were more frequent in the Injection group on day 1 and day 14 after therapy than in animals receiving epicardial or sham therapy (p < 0.05 and p < 0.01, respectively). EEPM under isoproterenol stress showed macroreentry at the infarct border area, leading to ventricular tachycardias in the Injection group, but not in the myoblast sheet- or sham-treated groups (p = 0.045). Both transplantation types modified the myocardial cytokine expression profile. In animals receiving epicardial myoblast therapy, selective reductions in the expressions of interferon gamma, interleukin (IL)-1β and IL12 were observed, accompanied by reduced infiltration of inflammatory CD11b- and CD68-positive leukocytes, compared with animals receiving myoblasts as intramyocardial injections. Intramyocardial myoblast delivery was associated with enhanced inflammatory and immunomodulatory reactivity and increased frequency of VPCs. In comparison to intramyocardial injection, the epicardial route may serve as the preferred method of skeletal myoblast transplantation to treat heart failure.
first_indexed 2024-12-11T22:03:25Z
format Article
id doaj.art-77716bcb04b7479485e249f6c12e28c2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T22:03:25Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-77716bcb04b7479485e249f6c12e28c22022-12-22T00:49:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012396310.1371/journal.pone.0123963Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.Tommi PätiläShigeru MiyagawaYukiko ImanishiSatsuki FukushimaAntti SiltanenEero MervaalaEsko KankuriAri HarjulaYoshiki SawaAlthough cell therapy of the failing heart by intramyocardial injections of myoblasts to results in regenerative benefit, it has also been associated with undesired and prospectively fatal arrhythmias. We hypothesized that intramyocardial injections of myoblasts could enhance inflammatory reactivity and facilitate electrical cardiac abnormalities that can be reduced by epicardial myoblast sheet delivery. In a rat model of ischemic heart failure, myoblast therapy either by intramyocardial injections or epicardial cell sheets was given 2 weeks after occlusion of the coronary artery. Ventricular premature contractions (VPCs) were assessed, using an implanted three-lead electrocardiograph at 1, 7, and 14 days after therapy, and 16-point epicardial electropotential mapping (EEPM) was used to evaluate ventricular arrhythmogenicity under isoproterenol stress. Cardiac functioning was assessed by echocardiography. Both transplantation groups showed therapeutic benefit over sham therapy. However, VPCs were more frequent in the Injection group on day 1 and day 14 after therapy than in animals receiving epicardial or sham therapy (p < 0.05 and p < 0.01, respectively). EEPM under isoproterenol stress showed macroreentry at the infarct border area, leading to ventricular tachycardias in the Injection group, but not in the myoblast sheet- or sham-treated groups (p = 0.045). Both transplantation types modified the myocardial cytokine expression profile. In animals receiving epicardial myoblast therapy, selective reductions in the expressions of interferon gamma, interleukin (IL)-1β and IL12 were observed, accompanied by reduced infiltration of inflammatory CD11b- and CD68-positive leukocytes, compared with animals receiving myoblasts as intramyocardial injections. Intramyocardial myoblast delivery was associated with enhanced inflammatory and immunomodulatory reactivity and increased frequency of VPCs. In comparison to intramyocardial injection, the epicardial route may serve as the preferred method of skeletal myoblast transplantation to treat heart failure.http://europepmc.org/articles/PMC4393220?pdf=render
spellingShingle Tommi Pätilä
Shigeru Miyagawa
Yukiko Imanishi
Satsuki Fukushima
Antti Siltanen
Eero Mervaala
Esko Kankuri
Ari Harjula
Yoshiki Sawa
Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
PLoS ONE
title Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
title_full Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
title_fullStr Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
title_full_unstemmed Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
title_short Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure.
title_sort comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure
url http://europepmc.org/articles/PMC4393220?pdf=render
work_keys_str_mv AT tommipatila comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT shigerumiyagawa comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT yukikoimanishi comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT satsukifukushima comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT anttisiltanen comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT eeromervaala comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT eskokankuri comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT ariharjula comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure
AT yoshikisawa comparisonofarrhythmogenicityandproinflammatoryactivityinducedbyintramyocardialorepicardialmyoblastsheetdeliveryinaratmodelofischemicheartfailure